This study is testing a new medicine called **AXS-05** to see if it helps with **agitation** (feeling restless or upset) in people with **Alzheimer's disease**, a brain condition that affects memory and thinking. The study will compare AXS-05 to a **placebo**, which is a pill that looks the same but doesn't have medicine. People in the study will not know which one they are taking, making it a **double-blind** study. The study will last up to 5 weeks.
To join, you need to have been diagnosed with Alzheimer's disease and have noticeable agitation. If you have a different kind of dementia or can't follow study rules, you can't join. The study takes place at different locations (**multi-center**), and participants will be chosen randomly (**randomized**) to get either AXS-05 or placebo.
- Study Duration: Up to 5 weeks
- No cost for the medication
- Potential benefits include reduced agitation symptoms
Talk to your doctor if you are interested in joining or want more information about the risks and benefits.